Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP ShZ TIV Trivalent Inactivated Influenza Vaccine Immunogenicity and Safety Study
CTR20140452Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent inactivated influenza vaccine in influenza, sponsored by Sanofi. Started Aug 2014; status: completed.
02
Drugs
trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20140452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140452.